Dr. Oyer on Tools for Clinicians to Use When Treating Patients With Cancer

Video
Conference|ASCO Annual Meeting

Randall A. Oyer, MD, oncology program, medical director, Lancaster General Health, treasurer, Association of Community Cancer Centers, discusses some of the tools clinicians could potentially use for their patients with cancer.

Randall A. Oyer, MD, oncology program, medical director, Lancaster General Health, treasurer, Association of Community Cancer Centers, discusses some of the tools clinicians could potentially use for their patients with cancer.

Related Videos
Jeremy M. Pantin, MD, clinical director, Adult Transplant and Cellular Therapy Program, TriStar Centennial Medical Center, bone marrow transplant physician, Sarah Cannon Research Institute
Maria Hafez, MD, assistant professor, breast and sarcoma medical oncologist, director, Clinical Breast Cancer Research, Sidney Kimmel Medical College, Thomas Jefferson University
Zeynep Eroglu, MD
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Akriti Jain, MD
Raj Singh, MD
Gottfried Konecny, MD
Karim Chamie, MD, associate professor, urology, the University of California, Los Angeles
Mike Lattanzi, MD, medical oncologist, Texas Oncology
Ramez N. Eskander, MD
Related Content
Richard T. Lee, MD, of City of Hope

The New Frontier With Integrative Oncology: Shooting for the Stars

April 11th 2024
Article
Dizon Discusses Elements of Sexual Health in Gynecologic Cancer

Dizon Discusses Elements of Sexual Health in Gynecologic Cancer

August 6th 2020
Podcast
Brooke Worster, MD, MS, FACP, of Jefferson Health

Unpacking the Role of Cannabis in Oncology as Reclassification of the Drug Pends

March 29th 2024
Article
Integrating Nutrition Into the Continuum of Cancer Care

Integrating Nutrition Into the Continuum of Cancer Care

June 18th 2020
Podcast
Noa Shelach, PhD, of Lutris Pharma

FDA Grants Orphan Drug Designation to LUT014 for EGFR Inhibitor–Induced Rash

February 28th 2024
Article
FDA

FDA Approves Delivery System of Biosimiliar Pegfilgrastim-cbqv for Febrile Neutropenia

December 26th 2023
Article